This R&D Briefing summarises the background and methodology of process mapping with examples to demonstrate the steps involved in regulatory, HTA and coverage processes for new medicines. In addition to their comparison and educational function, the process maps were utilised to address a number of research questions. The briefing highlights the outcome of these research studies and also outlines the practical utility of the process maps.